Verium successfully sells Dovida, a leading international home care provider, to Ardian, while maintaining a significant investment alongside the company's CEO Paul Fritz.
About the Target
Dovida is a premier international provider of non-medical home care services, holding leading positions in Switzerland, Ireland, the Netherlands, as well as in Australia and New Zealand. The company employs over 12,000 dedicated caregivers who work tirelessly to meet the needs of elderly individuals, enabling them to remain in their homes for as long as possible. Dovida offers a comprehensive range of services for senior care, including daily companionship, household assistance, basic care, overnight support, and dementia care. Over the past decade, Dovida has successfully advanced its international expansion through both organic growth and strategic acquisitions.
Industry Overview in Switzerland
The home care industry in Switzerland has witnessed significant growth in recent years, driven primarily by the aging population and a societal shift towards aging in place. With an increasing number of seniors preferring to receive care in their own homes rather than in institutions, demand for home care services has surged. This situation has encouraged both existing providers and new entrants to invest in expanding their service offerings to meet the diverse needs of the elderly.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Swiss government has also recognized the importance of home care, implementing policies that support its growth. Subsidies and regulatory frameworks have been establi
Similar Deals
Healthcare Holding Schweiz AG → Sevika Medical AG
2025
Galenica → Diagnostics Group GmbH (Labor Team Gruppe inkl. labor team w ag)
2025
Main Capital Partners → Polypoint
2025
Healthcare Holding Schweiz AG → Ino Medical Solutions GmbH
2025
Healthcare Holding Schweiz AG → MCM Medsys AG, Naropa Reha AG, MVB Medizintechnik AG
2024
Gyrus Capital → Essential Pharma
2024
Ardian
invested in
Dovida
in 2025
in a Other Private Equity deal